Skip to main content
. 2003 Mar;18(1):21–28. doi: 10.3904/kjim.2003.18.1.21

Figure 1.

Figure 1.

Overall survival of the 53 evaluable patients (median 16.7 months; estimated 4-year survival rate 25.4%).